Pfizer, BioNTech win FDA fast-track approval for two coronavirus vaccine candidates By David Sherfinski - The Washington Times Shares
Maryland man thinks he is one of the first people to be vaccinated against coronavirus By Shen Wu Tan - The Washington Times Shares
Pfizer reports encouraging, very early vaccine test results By The Associated Press - Associated Press Shares
Malfunctioning EpiPens could harm patients, companies say By LINDA A. JOHNSON - Associated Press Shares
Greece must restore its credibility, new prime minister says By BY DEMETRIS NELLAS and COSTAS KANTOURIS - Associated Press Shares
Pfizer will absorb Mylan, a $10 billion generic pharmaceutical company that is one of the biggest in Associated Press Shares
Future is in doubt for cheaper versions of biologic drugs By LINDA A. JOHNSON - Associated Press Shares
Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion Associated Press Shares
Pfizer, Novartis, Big Pharma drug companies to end price freeze, raise costs in new year By Tom Howell Jr. - The Washington Times Shares
AP FACT CHECK: Trump fudges history on black vote, drug cost By HOPE YEN and CALVIN WOODWARD - Associated Press Shares
AP FACT CHECK: Trump on Kavanaugh accuser, drug prices, vets By HOPE YEN and CALVIN WOODWARD - Associated Press Shares
AP investigation: Drug prices going up despite Trump promise By LINDA A. JOHNSON and NICKY FORSTER - Associated Press Shares
FDA approves first generic version of lifesaving EpiPen By Tom Howell Jr. - The Washington Times Shares
Pfizer 2Q profit surges, company sees drug rebates ending By LINDA A. JOHNSON - Associated Press Shares
